Molecular Therapeutics Research Program

Mission

The underlying mission of the Molecular Therapeutics (MT) Program is to translate laboratory findings to the clinic so as to improve the lives of patients with cancer by identifying new molecules, targets and strategies for treating cancer. This highly interactive program includes a cross section of laboratory-based scientists and physicians at Karmanos who meet regularly through programmatic activities, and serve as co-investigators on research grants and investigator-initiated clinical trials.

The MT Program’s overriding goal is to integrate basic and translational scientists working broadly in areas of drug development, new or established therapeutic targets or pathways, and cellular and genetic biomarkers of cancer, with physicians conducting interventional treatment trials at the Karmanos Cancer Institute.  

Scientific Themes

  1. Identify and validate new tumor targets and pathways and develop novel candidate therapeutics.
  2. Develop new imaging agents and technologies for cancer diagnosis and staging.
  3. Validate clinical effectiveness of new agents in interventional treatment trials.

Program Activities

The MT Program leadership actively supports:

  • Basic-clinical collaborations and translational research through the monthly program meetings
  • Molecular Therapeutics Special Seminars
  • Focused retreats
  • Small working groups or topical conferences
  • An annual Molecular Therapeutics Program Retreat
  • Targeted internal grants with emphasis on collaboration and translational science

Program Leaders

Yubin Ge, Ph.D.

Molecular Therapeutics Program Leader
Barbara Ann Karmanos Cancer Institute
Professor, Department of Oncology
Wayne State University School of Medicine
gey@karmanos.org

Eduard Chekmenev, Ph.D.

Molecular Therapeutics Program Co-Leader
Barbara Ann Karmanos Cancer Institute
Professor, Departments of Chemistry and Oncology
Wayne State University
chekmenev@wayne.edu

Hirva Mamdani, M.D.

Molecular Therapeutics Program Co-Leader
Thoracic Oncology Multidisciplinary Team Leader
Barbara Ann Karmanos Cancer Institute
Associate Professor, Departments of Medicine and Oncology
Wayne State University School of Medicine
mamdanih@karmanos.org

The Latest From Karmanos Cancer Institute

News

IN THE NEWS: Misconceptions About Cancer Clinical Trials and How to Overcome Them

Clinical Leader Patients may not be the only ones who may be apprehensive about participating in clinical trials; some physicians may be hesitant ...

Read More

Karmanos, WSU Researcher Receives NIH Award to Explore Socio-genomic Factors of Local Endometrial Cancer Survival Rates

The National Cancer Institute of the National Institutes of Health has awarded Anna Gottschlich, Ph.D., M.P.H., member of the Population Studies a...

Read More

Registration Now Open: Karmanos and Wayne State University’s 3rd Annual Lung Cancer Symposium

The Barbara Ann Karmanos Cancer Institute and Wayne State University will host the Third Annual Lung Cancer Symposium , bringing together some of ...

Read More
News

105.9 KISS FM | Getting a Second Opinion at Karmanos

Listen Now

WJR | Karmanos Cancer Institute Continues Its Community Education Series

Listen Now

WXYT 97.1 The Ticket | ‘Get a Mammogram’

Listen Now